Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0476089 (
endometrial cancer
)
11,379
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This is a general discussion of commonly seen oncology problems in gynecology for the general practitioner and the nongynecologic specialist. Vaginal, cervical, ovarian, and
endometrial cancer
are discussed. Studies have shown a possible relationship between perinatal exposure to DES(diethylstilbestrol) and clear cell adenocarcinoma of the vagina and cervix in young women. Of the more than 350 reported cases of this previously
rare disease
, 2/3 had a history of in utero exposure to DES. 80-90% of all exposed women show adenosis of the vagina. There is no evidence, however, that it is a precursor of cancer and no examples of the progression have been cited. All DES-exposed daughters should have yearly PAP smears and iodine staining or colposcopy of the vagina. The American College of Obstetricians and Gynecologists differs from the American Cancer Society in recommending yearly PAP smears to detect cervical cancer. There is no risk and no morbidity with the smear. Only the cost is a consideration.
Endometrial cancer
accounts for 7% of all cancers in women, occurring in 2.2% of all women. Survival rates with this type of cancer are 68% at 5 years. Some studies have implicated the use of postmenopausal estrogens with the etiology of
endometrial cancer
. Any abnormal bleeding should be checked. Ovarian cancer presents in more advanced stages and has a survival rate at 5 years of only 25%. Surgery and chemotherapy are the prescribed treatment for each of these cancers.
...
PMID:Gynecological malignancy. 724 64
In this paper, we report a new case of metastatic
endometrial carcinoma
to the vulva and describe the clinical and pathological features. We reviewed the literature to determine the frequency and to evaluate the prognostic significance of this
rare disease
. Moreover, we discuss the criteria for the differential diagnosis of
endometrial carcinoma
metastatic to the vulva, the primary vulvar adenocarcinomas, and other metastatic adenocarcinomas. The patient, previously diagnosed to have endometrial adenocarcinoma with squamous differentiation at III C stage (according to the FIGO system) and T2N1M0 stage (according to the TNM system), presented with a small plaque on the vulvar mucosa 8 months after endometrial primary carcinoma had been diagnosed. The histological evaluation of excisional vulvar biopsy revealed a neoplasm with pathological features of
endometrial carcinoma
. Thus, the final diagnosis was metastatic
endometrial carcinoma
to the vulva. A total body computed tomography scan (CT) and an echotomography with contrast medium revealed a second metastatic lesion at the 8th segment of the liver. No other metastatic lesions developed, nor was a reduction in the size of liver metastasis observed after 3 months of hormonic treatment with progesterone. Fourteen months after the diagnosis of primary
endometrial carcinoma
, the patient died of disseminated metastatic lesions. In conclusion, metastatic
endometrial carcinoma
to the vulva, although rare, might develop and could appear within a few months after the diagnosis of primary tumor. Moreover, in the presence of metastatic
endometrial carcinoma
to the vulva, it is necessary to verify if other visceral metastases are present.
...
PMID:Endometrial carcinoma metastatic to the vulva: a case report and review of the literature. 1632 18
Small cell neuroendocrine (NE) carcinoma is one of the most aggressive tumors that arise in the female genital tract. Small cell carcinoma of the endometrium (SCCE) is an extremely
rare disease
. Because of its rarity, the only clinical reports are limited to case studies, and therefore, clinical behavior and optimal treatment modalities are not well defined. To the best of our knowledge, we present the first case of SCCE staged by laparoscopic approach. A 54-year-old parous woman admitted with intermittent vaginal spotting. On physical examination, she had a 4- x 3-cm mass fungating out of the cervical os. Magnetic resonance imaging showed an endometrial mass of 25 x 30 x 50 mm in dimensions, invading less than 50% of the depth of the myometrium at the uterine fundus. Pathologic examination revealed undifferentiated malign NE tumor of endometrium of small cell type. The patient underwent laparoscopic hysterectomy, bilateral salpingo-oophorectomy, and laparoscopic pelvic and para-aortic lymphadenectomy. The disease was surgically staged as IB. Histologically, tumor cells were monotone, with scanty, ill-defined cytoplasm and hyperchromatic nuclei. Immunohistochemically, tumor showed positive immunoreactivity for P16, neuron-specific enolase, and synaptophysin. She underwent pelvic external radiation and brachytherapy postoperatively. Patient has no evidence of disease after 26 months of follow-up. Small cell NE
carcinoma of the endometrium
is an extremely rare and aggressive disease. With the availability of skilled endoscopic surgeons, laparoscopic management of women, even with SCCE in early stage, can be a feasible option.
...
PMID:Small cell neuroendocrine carcinoma of the endometrium and laparoscopic staging: a clinicopathologic study of a case and a brief review of the literature. 1786 42
Verrucous carcinoma of the endometrium is an exceedingly
rare disease
with only a few cases reported in the literature. We describe the case of a 68-year-old postmenopausal patient who presented with vaginal discharge. PAP smears were repeatedly reported negative and an endometrial curettage 2 years prior to the diagnosis only showed fragments of benign squamous epithelium. Because of continuous symptoms a hysterectomy was performed and revealed extensive squamous metaplasia of the endometrium with focal transition to verrucous carcinoma. This case demonstrates that benign appearing squamous epithelium in curettage specimens, especially when abundant, is not necessarily ordinary portio epithelium. In this setting, the clinical presentation becomes paramount for considering a well differentiated squamous
carcinoma of the endometrium
and avoiding diagnostic delay.
...
PMID:Verrucous carcinoma of the endometrium: a rare and challenging diagnosis. 2468 42
Xanthogranulomatous endometritis (XGE) is an extremely rare chronic inflammatory condition, which may be associated with endometrial hyperplasia,
endometrial carcinoma
, or cervical stenosis. Imaging features can be easily misdiagnosed as an aggressive malignancy. We present a case of XGE, which is the first case of XGE with serial multimodality imaging examinations, in addition to clinical, surgical and pathologic correlations. As such, this unique case illustrates the evolution of this
rare disease
.
...
PMID:Xanthogranulomatous endometritis mimicking endometrial carcinoma: A case report and review of literature. 3038 51
Muir-Torre syndrome is a rare subtype of Lynch syndrome characterized by coincidence of skin neoplasm and visceral malignancies. Here, we report a case of this
rare disease
, whose diagnosis of the syndrome was first suspected by the pathologist. This was a 60-yr-old woman who presented with an axillary skin nodule, which was diagnosed as basal cell carcinoma. Further inquiry revealed that she was hospitalized for evaluation of a recurrent vaginal stump
endometrial carcinoma
. Histologic workup and immunohistochemistry for mismatch repair proteins of both the skin and vaginal tumor suggested the possibility of Muir-Torre syndrome. NexGen sequencing identified a frame-shift mutation in the MSH2 gene. The patient was found to have a metachronous colorectal carcinoma, uterine
endometrial carcinoma
, and skin cancer from 1998 to 2016. Five family members had also suffered from colorectal cancer or glioma. This case report illustrates the importance of the multidisciplinary care approach, mismatch repair protein and gene testing, and detailed medical history taking into consideration the diagnosis of Muir-Torre syndrome.
...
PMID:Muir-Torre Syndrome With a Frame-shift Mutation in the MSH2 Gene: A Rare Case Report and Literature Review. 3203 37